CTNM affiliate files Form 144 for multiple 10b5-1 stock sales

CTNM affiliate reported planned sales of Common Stock via Form 144.

Rhea-AI Filing Summary

CTNM affiliate reported planned sales of Common Stock via Form 144. The filing lists multiple 10b5-1 programmed sales by Daniel Lorrain on several dates in 2026, including trades of 4,170, 3,824, 4,300, and other share amounts with indicated proceeds per trade. The filing names Morgan Stanley Smith Barney LLC as the broker and shows the securities type as Restricted Stock Units dated 05/09/2017.

Insights

Equity Markets Analyst

Multiple automated (10b5-1) sales by an affiliate are disclosed; they represent routine liquidity events.

The filing lists several dated sales executed under a 10b5-1 plan, including transactions of 4,170 and 3,824 shares. These are recorded as separate programmed trades with per-trade proceeds shown.

Timing is execution-based; subsequent filings would show completion or additional planned sales. The cash‑flow recipient is the selling affiliate; specific use of proceeds is not stated in the excerpt.

Key Figures

Trade quantity example: 4,170 shares Trade quantity example: 3,824 shares Trade quantity example: 4,300 shares +3 more

6 metrics

Trade quantity example 4,170 shares sale dated 04/06/2026 under 10b5-1

Trade quantity example 3,824 shares sale dated 02/25/2026 under 10b5-1

Trade quantity example 4,300 shares sale dated 02/24/2026 under 10b5-1

Smaller trades 400 shares; 100 shares sales dated 02/11/2026 and 02/19/2026 under 10b5-1

RSU award date 05/09/2017 Restricted Stock Units grant date shown in securities section

Per-trade proceeds example $62,305.22 proceeds shown for sale of 4,170 shares on 02/03/2026

Key Terms

10b5-1, Form 144, Restricted Stock Units

3 terms

10b5-1 regulatory

"10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Securities To Be Sold | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CTNM's Form 144 disclose about insider sales?

The filing discloses planned sales of Common Stock by an affiliate under a 10b5-1 plan. It lists multiple dated trades in 2026 and share quantities such as 4,170 and 3,824.

Who executed the sales listed in the CTNM Form 144?

The sales are attributed to Daniel Lorrain and list Morgan Stanley Smith Barney LLC as the broker. Transactions are described as 10b5-1 programmed sales on specific dates in 2026.

What securities type is referenced in the Form 144 for CTNM?

The filing references Common stock linked to Restricted Stock Units with an award date of 05/09/2017. The RSU award date is shown in the securities section.

How many shares were sold in individual trades shown?

Individual trade quantities shown include 4,170, 3,824, 4,300, 400, and 100 shares across various 2026 dates, with proceeds listed per trade.

Do the Form 144 entries indicate whether these sales were pre‑arranged?

Yes. The entries are labeled as 10b5-1 Sales, indicating the trades were executed under pre‑arranged trading plans rather than ad‑hoc open‑market decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 04:47 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001861550
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Contineum Therapeutics, Inc.
SEC File Number	001-42001
Address of Issuer	3565 General Atomics Court, Suite 200 San Diego CALIFORNIA 92121
Phone	8583335280
Name of Person for Whose Account the Securities are To Be Sold	DANIEL LORRAIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4170	53459.40	32673536	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2017	Restricted Stock Units	Issuer			4170	05/09/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	04/06/2026	4170	56013.94
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	03/02/2026	4170	62585.03
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	02/25/2026	3824	61227.91
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	02/24/2026	4300	68936.04
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	02/19/2026	100	1600.00
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	02/11/2026	400	6400.00
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	02/03/2026	4170	62305.22

144: Remarks and Signature

Remarks
Date of Notice	05/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Lorrain
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)